RU93005244A - DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION - Google Patents
DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- RU93005244A RU93005244A RU93005244/04A RU93005244A RU93005244A RU 93005244 A RU93005244 A RU 93005244A RU 93005244/04 A RU93005244/04 A RU 93005244/04A RU 93005244 A RU93005244 A RU 93005244A RU 93005244 A RU93005244 A RU 93005244A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- hydrogen
- optionally protected
- halo
- quinoline
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003248 quinolines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000004953 trihalomethyl group Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 0 *C(*)(C(C=C1)c2c1cc*c2)c1ccccc1 Chemical compound *C(*)(C(C=C1)c2c1cc*c2)c1ccccc1 0.000 description 1
Claims (1)
в котором R1 - водород, гало, C1 - 4-алкил, C1 - 4-алкоксил, нитрил, возможно защищенная карбоксильная группа, возможно защищенный тетразолил, тригалоидметил, окси-C1=00-4-алкил, альдегин, -CH2Z, -CH=CH-Z или -CH2CH2Z , где Z - возможно защищенная карбоксильная группа или возможно защищенный тетразолил; R2 - гало, нитрил, возможно защищенная кислотная группа или -CONR7R8, где R7 и R8 - каждый водород или C1 - 4-алкил, R3 и R4 - каждый водород, C1 - 4-алкил, возможно замещенный фенил, или C1 - 4-алкил, замещенный группой -CONR7R8 или возможно защищенной кислотной группой;
где W - -CH= CH-, CH= N-, -N= CH-, -O- или -S-, R9 - водород, гало, C1 - 4-алкил, C1 - 4-алкоксил или тригалоидметил и R1 0 - водород, C1 - 4-алкил,
C2 - 6-алкенил, C3 - 6-циклоалкил или C1 - 4-алкил, C3 - 6-циклоалкил; R6 - водород или C1 - 4-алкил; X - -O-(CH2)nCR1 1CR1 2 или -CR1 1-Cr1 2, где R1 1, R1 2, R1 3 и R1 4 - каждый водород или C1 - 4-алкил, и n - 0, 1 или 2; Y - -O-CR1 5R1 6-, CR1 5=CR1 6 или Cr1 5R1 6 • CR1 7R1 8-, где R1 5, R1 6, R1 7 и R1 8 - каждый водород или C1 - 4-алкил; или их соль. Соединения в незащищенной форме являются активными лейкотриновыми антагонистами.Compound of formula
wherein R 1 - hydrogen, halo, C 1 - 4 alkyl, C 1 - 4 -alkoxy, nitrile, optionally protected carboxyl group, optionally protected tetrazolyl, trihalomethyl, hydroxy-C 1 = 00- 4 -alkyl aldegin - CH 2 Z, —CH═CH — Z or —CH 2 CH 2 Z, where Z is optionally protected carboxyl group or optionally protected tetrazolyl; R 2 - halo, nitrile, an optionally protected acid group or -CONR 7 R 8 where R 7 and R 8 - are each hydrogen or C 1 - 4 alkyl, R 3 and R 4 - are each hydrogen, C 1 - 4 alkyl optionally substituted phenyl, or C 1 - 4 alkyl substituted by -CONR 7 R 8 or optionally protected acid group;
where W - -CH = CH-, CH = N-, -N = CH-, -O- or -S-, R 9 - H, halo, C 1 - 4 alkyl, C 1 - 4 -alkoxy or trihalomethyl and R 1 0 is hydrogen, C 1 - 4 alkyl,
C 2 - 6 -alkenyl, C 3 - 6 -cycloalkyl or C 1 - 4 alkyl, C 3 - 6 -cycloalkyl; R 6 - hydrogen or C 1 - 4 alkyl; X - -O- (CH 2 ) n CR 1 1 CR 1 2 or -CR 1 1 -Cr 1 2 , where R 1 1 , R 1 2 , R 1 3 and R 1 4 - each hydrogen or C 1 - 4 -alkyl, and n - 0, 1 or 2; Y - -O-CR 1 5 R 1 6 -, CR 1 5 = CR 1 6 or Cr 1 5 R 1 6 • CR 1 7 R 1 8 -, where R 1 5 , R 1 6 , R 1 7 and R 1 8 - each hydrogen or C 1 - 4 alkyl; or their salt. Unprotected compounds are active leukotrin receptor antagonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9107486.4 | 1991-04-09 | ||
GB9016790.9 | 1991-04-09 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU5001275 Division |
Publications (1)
Publication Number | Publication Date |
---|---|
RU93005244A true RU93005244A (en) | 1996-05-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69925141D1 (en) | CHINAZOLINE DERIVATIVES | |
KR910000735A (en) | Fused 2, 3-dihydroxypyrazine and preparation method thereof | |
CA2376304A1 (en) | Amide substituted imidazoquinolines | |
RU92004429A (en) | DERIVATIVES 2- (1-PIPERASINIL) -4-PHENYL-CYCLO-ALKANOPYRIDINE | |
KR900016186A (en) | 5-alkylquinolone carboxylic acid | |
RU98111511A (en) | TRICYCLIC PYRAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | |
RU95114449A (en) | Derivatives of 4-aryl- or heteroaryl-6-amino-nicotinic acid, a mixture of their isomers or separate isomers, and also a pharmaceutical composition with a modulatory cali num ate ia i'm i'm i'm i'm i'm going | |
RU95115522A (en) | CONNECTION SUITABLE FOR THE TREATMENT OF CNS DISEASES, PHARMACEUTICAL COMPOSITION | |
RU93056600A (en) | PHENOXY- AND PHENOXIALKYLPIPERIDINE COMPOUNDS AND ANTI-VIRUS COMPOSITION | |
RU2002102551A (en) | New derivatives of piperazinylalkylthiopyrimidine, pharmaceutical compositions containing them and a method for preparing the active substance | |
KR880000413A (en) | Anti-allergic and anti-inflammatory preparations and preparation methods thereof | |
EP0387070A3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
KR940011450A (en) | Fungicidal 2-alkoxy-2-imidazolin-5-one derivatives | |
RU93005244A (en) | DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION | |
KR930021638A (en) | Imidazopyridine | |
ES2104370T3 (en) | DERIVATIVES OF (ARYLALKYLAMINOBENCIL) SUBSTITUTED AMINOPROPIONAMIDES, THEIR PREPARATION AND USE. | |
KR910005871A (en) | Cephalosporin Injection Preparations | |
ATE182138T1 (en) | N-(2-(PYRROLIDINYL-1)-1-PHENYLETHYL>ACETAMIDE AS KAPPA RECEPTOR AGONISTS | |
ES520774A0 (en) | PROCEDURE FOR THE PREPARATION OF THYOMETHYLPIRIDINE DERIVATIVES. | |
YU47839B (en) | PROCEDURE FOR OBTAINING HINOLIN BENZIL INDOLA DERIVATIVES AND ITS DERIVATIVES | |
KR930021629A (en) | Piperazine Derivatives | |
KR950032146A (en) | Triazole compound and method for preparing same and use thereof | |
KR880005090A (en) | 1.3-disubstituted imidazolium salts | |
ATE318800T1 (en) | INDOLE DERIVATIVES AS MCP-1 RECEPTOR ANTAGONISTS | |
EP0127150A3 (en) | 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same |